Literature DB >> 7946513

Advantages and disadvantages of using human cells for pharmacological and toxicological studies.

G M Hawksworth1.   

Abstract

1. Marked species differences in the distribution and affinity of drug receptors, and in the patterns of biotransformation and susceptibility to the toxicity of xenobiotics, provide the impetus for using human tissues for pharmacological and toxicological studies. 2. Studies with intact cells facilitate the correlation of xenobiotic metabolism with cellular indices of toxicity, which can provide the mechanistic basis for understanding species differences in toxicity. 3. Human cells in suspension or primary culture reflect the variability in susceptibility to toxicity in a population. 4. The current limitation to these studies is scarcity of human material, the need for improved (cryo)preservation techniques for human hepatocytes/precision-cut slices and difficulties in predicting in vivo exposure-risk relationships from in vitro dose-response relationships.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946513     DOI: 10.1177/096032719401300811

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  4 in total

1.  Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture.

Authors:  Jeanine L Page; Mary C Johnson; Katy M Olsavsky; Steven C Strom; Helmut Zarbl; Curtis J Omiecinski
Journal:  Toxicol Sci       Date:  2007-02-27       Impact factor: 4.849

2.  Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.

Authors:  Takayuki Koga; Pei-Li Yao; Maryam Goudarzi; Iain A Murray; Gayathri Balandaram; Frank J Gonzalez; Gary H Perdew; Albert J Fornace; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2016-10-20       Impact factor: 5.157

Review 3.  Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.

Authors:  T J Maguire; E Novik; P Chao; J Barminko; Y Nahmias; M L Yarmush; K-C Cheng
Journal:  Curr Drug Metab       Date:  2009-12       Impact factor: 3.731

4.  Suitability of Human Mesenchymal Stem Cells Derived from Fetal Umbilical Cord (Wharton's Jelly) as an Alternative In Vitro Model for Acute Drug Toxicity Screening.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Andreas Kritikos; Panagiotis Zoumpourlis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.